Cancer Progression : Focus on Platelet
DOI:
https://doi.org/10.32539/bsm.v5i2.197Keywords:
Platelet, Cancer, Thrombosis, MetastasisAbstract
Platelets are an important component in the process of hemostasis and coagulation. It’s
now known that high platelets count closely related to poor prognosis of patients with
cancer, due to their role in the hematogenous spread of cancer cells. Platelet can be
activated by cancer cells into tumor educated platelet and then cause thrombosis through
tumor induced platelet aggregation. Platelet also protect cancer cells in the blood circulation
from natural killer cells and help the transition of cancer cells from epithelial to
mesenchymal and vice versa, resulting in the process of metastasis. In the next stage of
metastasis, platelets trigger extravasation of cancer cells from primary cancer and help
adhesion of cancer cells to distant organs.
Authors
- Erty Sundarita1*
- Mediarty2
- 1Trainee of Medical Hematology and Oncology, Internal Medicine Department, Faculty of Medicine, Universitas Sriwijaya, Palembang, South Sumatera, Indonesia.
- 2Division of Medical Hematology and Oncology, Internal Medicine Department, Faculty of Medicine , Universitas Sriwijaya, Palembang, South Sumatera, Indonesia.
Corresponding author Erty Sundarita — ertysundarita@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
